300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Retail
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Mobile Apps
Climate
Music
Art
Life Science
Real Estate
Sporting Goods
Wine and Spirits
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Food and Beverage
Franchise
Publishing
Mobile Advertising
Non Profit
Android
Internet
Sustainability
Hardware
Enterprise
Biotech
Impact
Community
Proptech
Media (Entertainment)
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Canada
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
United Kingdom
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Chishima Real Estate, VC Fund

Chishima Real Estate

VC Fund

Osaka, Japan

Chishima Real Estate is a VC fund in Osaka focused on Apps and Manufacturing. Chishima Real Estate engages in a range of business including real estate, aircraft leasing, and regional revitalization activities.

Total investments:
12
Last investment:
Lead investor:
8%

Last updated:

Industries Chishima Real Estate invests in

AppsManufacturingArtFuelSales

Stages Chishima Real Estate invests in

Series BSeries CFunding RoundDebt FinancingVenture - Series Unknown

Countries Chishima Real Estate invests in

JapanUnited States

Round sizes

Series B $7.6M–$11MSeries C $6.8M–$12M

Round size

Series B
$7.6M–$11M
Series C
$6.8M–$12M

Investment Focus

Industry

  • Apps 2 (17%)
  • Manufacturing 2 (17%)
  • Art 1 (8%)
  • Fuel 1 (8%)
  • Sales 1 (8%)
See all 34 industries →

Stage

  • Series B 2 (17%)
  • Series C 2 (17%)
  • Funding Round 2 (17%)
  • Debt Financing 2 (17%)
  • Venture - Series Unknown 2 (17%)
See all 7 stages →

Country

  • Japan 10 (83%)
  • United States 1 (8%)

Investments

CompanyDescriptionRoundLinks
Bee Informatica Bee Informatica
Bee Informatica is a fintech startup offering digital microfinance and alternative credit scoring solutions for underserved SMEs. Utilizing psychometric testing and behavioral analytics, the company enables fair lending access to entrepreneurs lacking traditional credit histories. Their platform supports inclusive economic growth through innovativefinancial services.​ $912.5K / Debt Financing / Jun 08, 2026
Monochrome Monochrome
Monochrome is creating a home operating system in order to power the next generation of energy-producing homes and roofs. The company is based in Chuo Ward, Tokyo. $10.7M / Series B / Apr 22, 2026
Manpuku Holdings Manpuku Holdings
Manpuku Holdings is a food and beverage company that specializes in sushi, yakiniku, fried chicken, bento, and rice balls. $12.2M / Series C / Dec 01, 2025
Knowhere Knowhere
Knowhere is a company that applies high-performance AI to sports. $3.4M / Venture - Series Unknown / Apr 17, 2025
Thinkr Thinkr
THINKR provides advertising, video production, content, UX design, and animation services. $32.5M / Series A / Jul 26, 2024
CLAS CLAS
Class is a connection between people, the value of money, time and things. $7.6M / Series B / Jan 24, 2024
DG Fuels DG Fuels
DG Fuels focuses on the production of synthetic jet fuel and then later synthetic diesel fuel. The electric power for the manufacturing processes comes largely from renewable solar and wind energy initially to be produced by other entities. Debt Financing / Jul 28, 2023
Dank1 Dank1
DanKichi Ltd. plans, develops, and operates a smartphone app dedicated to sports. It was founded on February 14, 2013, and is based in Osaka, Japan. $410.1K / Venture - Series Unknown / May 28, 2021
Kringle Pharma Kringle Pharma
Kringle Pharma, Inc., a biopharmaceutical company, develops pharmaceutical products based on its research on hepatocyte growth factor (HGF) and NK4. Its HGF has the regenerative healing ability in regard to liver cells, as well as various cells and organs; and NK4 is a bi-functional molecule, which inhibits the invasion and metastasis of tumorcells as an HGF-antagonist, as well as possesses antiangiogenic activity. The company’s pipeline includes recombinant human HGF for the treatment of acute renal failure, skin ulcers, and CNS diseases; and recombinant human NK4 and NK4 gene drugs for cancer therapy. Kringle Pharma, Inc. was founded in 2001 and is based in Toyonaka, Japan. $104.9M / Apr 04, 2020
Kringle Pharma Kringle Pharma
Kringle Pharma, Inc., a biopharmaceutical company, develops pharmaceutical products based on its research on hepatocyte growth factor (HGF) and NK4. Its HGF has the regenerative healing ability in regard to liver cells, as well as various cells and organs; and NK4 is a bi-functional molecule, which inhibits the invasion and metastasis of tumorcells as an HGF-antagonist, as well as possesses antiangiogenic activity. The company’s pipeline includes recombinant human HGF for the treatment of acute renal failure, skin ulcers, and CNS diseases; and recombinant human NK4 and NK4 gene drugs for cancer therapy. Kringle Pharma, Inc. was founded in 2001 and is based in Toyonaka, Japan. $6.8M / Series C / Mar 02, 2020
See all 12 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Retail
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Mobile Apps
Climate
Music
Art
Life Science
Real Estate
Sporting Goods
Wine and Spirits
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Food and Beverage
Franchise
Publishing
Mobile Advertising
Non Profit
Android
Internet
Sustainability
Hardware
Enterprise
Biotech
Impact
Community
Proptech
Media (Entertainment)
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Canada
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
United Kingdom
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Chishima Real Estate invest in?

Chishima Real Estate invests primarily in Apps, Manufacturing and Art startups, most often at Series B and Series C stage. Most of the 12 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Chishima Real Estate's check size?

Chishima Real Estate typically joins rounds of $7.6M–$11M at Series B and $6.8M–$12M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Chishima Real Estate participates in.

When did Chishima Real Estate last invest?

The most recent investment recorded for Chishima Real Estate closed in Jun 2026. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Chishima Real Estate Chishima Real Estate Find emails